9 Other financial result
€ million |
|
2021 |
|
2020 |
|---|---|---|---|---|
|
|
|
|
|
Income from profit and loss transfer agreements |
|
43 |
|
23 |
Cost of loss absorption |
|
–81 |
|
–103 |
Other income from equity investments |
|
315 |
|
91 |
Other expenses from equity investments |
|
–210 |
|
–433 |
Income from marketable securities and loans |
|
164 |
|
–230 |
Realized income of loan receivables and payables in foreign currency |
|
753 |
|
1,097 |
Realized expenses of loan receivables and payables in foreign currency |
|
–928 |
|
–1,620 |
Gains and losses from remeasurement and impairment of financial instruments |
|
94 |
|
–61 |
Gains and losses from fair value changes of hedging instruments/derivatives not included in hedge accounting |
|
–648 |
|
1,950 |
Gains and losses from fair value changes of hedging instruments/derivatives included in hedge accounting |
|
36 |
|
20 |
Other financial result |
|
–463 |
|
733 |
Gains and losses from fair value changes of hedging instruments/derivatives not included in hedge accounting include primarily losses on the measurement and realization of forward purchase agreements for new shares in QuantumScape Corporation in an amount of €0.6 billion (previous year: gains of €1.4 billion).